Learn More
Medchemexpress LLC GSK180736A | 817194-38-0 | 98.8% | 365.36 | 50 MG

Supplier: Medchemexpress LLC HY1899050MG
GSK180736A is a potent Rho-associated coiled-coil kinase 1 (ROCK1) inhibitor with an IC50 of 100 nM. It is also a selective and ATP-competitive G protein-coupled receptor kinase 2 (GRK2) inhibitor with an IC50 of 0.77 μM. Structurally similar to paroxetine, it shows more potency and selectivity for GRK2 than other GRKs. ROCK1 is a potential therapeutic target in cardiovascular diseases like hypertension, and GSK180736A is a weak inhibitor of PKA with an IC50 of 30 μM.
- Potent rho-associated coiled-coil kinase 1 (ROCK1) inhibitor (IC50 = 100 nM)
- Selective and ATP-competitive G protein-coupled receptor kinase 2 (GRK2) inhibitor (IC50 = 0.77 μM)
- Structurally similar to paroxetine
- More than 100-fold selectivity over other GRKs
- Potential therapeutic agent for cardiovascular diseases such as hypertension
- Weak PKA inhibitor (IC50 = 30 μM)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.